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Abstract Spatially and temporally regulated somatic muta-
tions can be achieved by using the Cre/loxP recombination sys-
tem of bacteriophage P1. To develop a cell type-speci¢c system
of gene targeting in the peripheral nervous system, we generated
the transgenic mouse lines expressing Cre recombinase under
the control of the mouse peripherin gene promoter. The activity
of the Cre recombinase during embryonic development was ex-
amined by mating the peripherin-Cre transgenic mice to the
knock-in Cre-mediated recombination reporter strain, R26R.
Analysis of F1 embryos from this cross showed speci¢c excision
of loxP-£anked sequences in the dorsal root ganglia, trigeminal
ganglia, and olfactory epithelium, in a pattern very similar to
the expression of the endogenous mouse peripherin gene, and the
previously reported peripherin-lacZ transgenic mice. Thus, the
peripherin-Cre mouse described here will provide a valuable tool
for Cre-loxP-mediated conditional expression in the peripheral
nervous system. ) 2002 Published by Elsevier Science B.V. on
behalf of the Federation of European Biochemical Societies.
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1. Introduction
Exploration of gene functions and development of mouse
models for human diseases are routinely based on genomic
manipulation via homologous recombination in embryonic
stem cells. Conventional gene knock-outs generate inherited
mutations in all cells, which may lead to embryonic lethality
and therefore hamper the ability to analyze gene function or
dysfunction during the postnatal period [1,2].
The Cre/loxP site-speci¢c recombination system derived
from bacteriophage P1 provides a convenient tool for spa-
tially and temporally regulated somatic mutations [3,4] and
e⁄ciently promotes recombination between two 34 bp loxP
recognition sequences. The sequences can be inserted at tar-
geted genomic sites of embryonic stem cells through conven-
tional ES cell techniques and homologous recombination [5].
Two loxP sequences £anking the interested genomic region
allow the loxP-£anked gene region to be deleted only in cells
expressing Cre recombinase. Therefore, spatial and/or tempo-
ral excision will depend on the promoter activity driving the
Cre recombinase expression.
Peripherin is a neuron-speci¢c type III intermediate ¢la-
ment protein expressed uniquely in the peripheral nervous
system [6]. This peripheral-speci¢c neuronal expression makes
the peripherin gene promoter an ideal candidate to drive ex-
pression of the Cre recombinase to just these neurons. The
long-term goal is to use the Per-Cre mouse in conjunction
with loxP-inserted mice, to create conditionally expressed
knock-out mice and examine the role of peripheral neuron
proteins in mouse models of pain, morphine analgesia and
in£ammation. The loxP-inserted genes will be discussed in
future publications. Here we describe the newly developed
transgenic mouse line carrying the Cre gene under control
of the mouse peripherin gene promoter [7]. To test and mon-
itor the e⁄ciency and tissue speci¢city of Cre-mediated re-
combination, we bred the peripherin-Cre (PCRE) transgenic
mice with the R26R mouse that harbors a Cre reporter gene
construct. The R26R mouse has a ROSA26 gene that has
been modi¢ed to harbor a loxP-£anked NeoR cassette which
when excised allows the ROSA26 gene promoter to drive ex-
pression of the Escherichia coli lacZ gene [8]. In this trans-
genic Cre strategy, the expression of Cre is induced as soon as
the transgene is turned on. In the case of the peripherin gene
promoter, the turn on is around E10 in the mouse embryo.
The deletion induced by Cre will be irreversible, resulting in
the removal of all loxP-£anked sequences from this early time
in development. Analysis of the F1 embryos by X-gal staining
suggests that four out of ¢ve peripherin-Cre transgenic mouse
lines target Cre recombinase expression to the dorsal root
ganglia, trigeminal ganglia and olfactory epithelium in a spa-
tial and temporal pattern nearly identical to that of the en-
dogenous mouse peripherin gene.
2. Materials and methods
2.1. Construction of peripherin-Cre transgene
Intragenic sequences of the murine peripherin gene including a
portion of the ¢rst exon, the complete ¢rst intron, second exon, sec-
ond intron and third exon, and the ¢rst half of the third intron (P2:
+357 to +1460) were isolated as an 1.1 kb fragment after SmaI di-
gestion of pGNP1P2 plasmid [7]. pPEC plasmid contains the mouse
5P-£anking region of the peripherin gene which corresponds to the
mouse peripherin promoter (P1), Cre recombinase and the MT-1
polyadenylation. The 1.1 kb SmaI fragment (P1) from pGNP1P2
was subcloned into the HindIII site of pPEC, following Klenow ¢ll-
in. The resultant clone, pPCRE, corresponds to the mouse peripherin
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promoter (P1) fused to the Cre recombinase transgene with the 1.1 kb
of contiguous transcribed sequence of the mouse peripherin gene (Fig.
1A).
2.2. Generation of transgenic lines and screening of transgenic mice
The injection ready Per-Cre linear DNA fragment was prepared by
digestion of the pPCRE vector with the restriction enzyme ApaI, that
removes all vector sequences. Generation of transgenic mice was per-
formed as described in Donovan [9] and founder mice were identi¢ed
with Cre primers as in Le and Sauer [10]. Expression from those
founders that demonstrate germ line transmission of the transgene
is described in this work. All animal housing and treatment complies
with NIH/AAALAC guidelines.
2.3. Analysis of the transgene expression
To test the e⁄ciency of Cre-mediated site-speci¢c recombination,
we used R26R reporter mice (Jackson Laboratories), a gene targeted
mouse line that directs expression of the E. coli lacZ, upon Cre-medi-
ated excision of the loxP-£anked NeoR cassette located upstream of
the lacZ sequences [8]. L-Galactosidase expression was assayed in
embryos from crosses between transgenic mice and homozygous
R26R reporter mice. Per-Cre+ embryos were identi¢ed using PCR
ampli¢cation analysis of Cre transgenes. The day of appearance of
the vaginal plug was designated E0. The histochemical staining pro-
cedure for L-galactosidase activity was used to detect lacZ expression
in whole embryos [11,12]. To analyze the spatial and temporal pattern
of transgene expression in the various lines, embryos were removed
from pregnant females at various days of gestation and analyzed for
lacZ activity. Embryos were dissected in sterile phosphate-bu¡ered
saline pH 7.4 (PBS) and ¢xed in 0.2% glutaraldehyde, 5 mM
EDTA, 2 mM MgCl2 in PBS for one or several hours at 4‡C depend-
ing on their size. After three washes in washing bu¡er (1.5 mM
MgCl2, 0.01% deoxycholate, 0.01% NP40 in PBS), staining was car-
ried out overnight at 37‡C in PBS containing 3.1 mM potassium
ferricyanide, 3.1 mM potassium ferrocyanide, 1 mM MgCl2 and
1 mg/ml X-gal. Embryos were rinsed in PBS, dehydrated in ethanol
and cleared in xylene before photography. The stained embryos were
embedded in para⁄n wax and sectioned at 10 Wm. Sections were
dewaxed, rehydrated and immunostained with a rabbit polyclonal
antibody against peripherin (1/200; Chemicon) and with a goat
anti-rabbit Texas red secondary antibody (Dako). Stained structures
were identi¢ed according to published procedures [13,14].
3. Results
In order to develop a mouse model of cell type-speci¢c gene
targeting in the peripheral nervous system, we fused the
mouse peripherin gene promoter to the Cre recombinase
cDNA. The construct also contains a polyadenylation signal
and 1.1 kb of contiguous transcribed sequence of the mouse
peripherin gene (Fig. 1A). Laurence Leconte et al. described a
nearly identical construct fused to lacZ with a similar pattern
of lacZ expression speci¢c to the peripheral nervous system
[7]. Seven founder transgenic mice carrying the peripherin-Cre
transgene were selected based on the PCR genotyping of the
Cre recombinase transgene. Five of these demonstrated germ-
line transmission of the transgene and were characterized fur-
ther (Fig. 1B). Peripherin-Cre transgenic lines were crossed
with homologous R26R Cre reporter mice. The progeny of
this cross that are heterozygous for the ROSA26 knock-in
allele, and inherit the Cre transgene, undergo Cre-mediated
excision of the NeoR cassette restoring lacZ expression specif-
ically in the Cre expressing cells, allowing production of the
L-galactosidase protein [8]. Of the ¢ve lines demonstrating
germline transmission, four (PCRE35, PCRE25, PCRE59,
PCRE11) yield detectable L-galactosidase activity, re£ecting
Cre recombinase activity (Table 1).
In order to characterize PCRE expression during develop-
ment, timed pregnancy embryos resulting from PCREU
R26R/R26R matings were analyzed at di¡erent developmental
stages. Endogenous peripherin expression appears early in the
mouse embryos starting between embryonic day 9 (E9) and
E10 [15]. By E14, peripherin is detectable in subsets of neu-
rons in virtually all of the various nervous system structures
where the gene is expressed in the adult. It is di⁄cult to isolate
some of these structures from adult animals, due to the di¡use
nature of the peripheral nervous system, and the opacity of
the adult tissues innervated by these neurons. Therefore, E14
Fig. 1. Peripherin-Cre transgenic mouse production. A: Physical map of the peripherin-Cre construct used to generate peripherin-Cre transgenic
mouse. The construct contains 5.8 kb of the 5P-upstream promoter region of the mouse peripherin (P1) gene linked to the Cre recombinase
gene (Cre) with an addition of 1.1 kb of intragenic sequences of the mouse peripherin gene (P2). This 1.1 kb fragment (P2) includes part of the
¢rst exon, ¢rst intron, second exon, second intron and part of the third exon. B: PCR genotyping, founder line determination using Cre prim-
ers (arrows) and tail DNA extracted from founder mice. Representative samples depicting the presence of a single 411 bp fragment of the Cre
recombinase indicate a positive (+) genotype.
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was chosen as the time point to analyze transgene expression
in all ¢ve transgenic lines both in whole-mount embryos and
para⁄n sections (Figs. 2 and 3).
At E14, the lacZ staining observed in the dorsal root gan-
glia (DRG), trigeminal ganglia (and cranial nerve V) and
olfactory epithelium was consistent for all four lines (35, 25,
59, 11) (Table 1, Figs. 2 and 3). Two lines, 35 and 59, were
analyzed in more detail at earlier stages, E10 and E11, while
line 35 was also analyzed at E16. E16 embryos from line 35
had an identical lacZ staining pattern as the E14 embryos,
except that the sympathetic ganglia neurons were also stained
positive (Table 1). Despite a nearly identical lacZ staining
pattern reported earlier for a peripherin-lacZ transgene con-
struct [7], lacZ staining was not detected at E10 and E11 in
both line 35 and line 59 (line 59 data not shown), suggesting a
slightly di¡erent temporal expression for the PCRE constructs
(Table 1). Embryos that were genotypically negative for the
PCRE transgene did not show any staining at any of the
stages observed. The spatial expression pattern of the PCRE
transgene is consistent with the X-gal staining pattern from
the peripherin-lacZ transgenic lines where lacZ expression is
driven by nearly identical peripherin gene sequences [7], as
well as immunohistochemical analyses of the peripherin pro-
tein in both mouse [15] and rat embryos [16]. In dorsal root
ganglia, all neuronal classes known to be dependent of TrkA,
B or C and having distinct soma diameter distributions were
equivalently stained by lacZ (data not shown). The strong
lacZ staining in DRG and trigeminal ganglia indicates an
e⁄cient Cre recombinase activity restricted to peripheral sen-
sory neurons.
4. Discussion
The goal of this work was to create a mouse with Cre
expression that could be used to conditionally knock-out the
expression of loxP-modi¢ed genes in just the peripheral ner-
vous system. We describe a peripherin-Cre transgenic mouse
that places the Cre recombinase under the transcriptional con-
trol of the murine peripherin gene promoter. Peripherin is a
neuron-speci¢c type III intermediate ¢lament protein ex-
pressed in well-de¢ned populations of neurons. Its expression
initiates soon after neurons become post-mitotic [6]. Ontogeny
studies of peripherin gene expression in mice indicate that
peripherin is found developmentally only in regions where it
is later found in the adult [15]. The peripherin gene promoter
was chosen for this construct due to earlier studies in trans-
genic mice that identi¢ed the peripherin promoter sequences
required for cell type-speci¢c peripherin gene expression [7].
The speci¢city of Cre activity was determined by using a
knock-in Cre reporter mouse, R26R [8]. Cre-mediated recom-
bination can be monitored with single-cell resolution by using
reporter mouse strains harboring a £oxed cassette which,
when deleted, allows the expression of a reporter protein,
such as L-galactosidase [5,17]. The Cre reporter mouse strain
utilized for this work, R26R Cre reporter strain, takes advan-
Table 1
Comparison of tissue speci¢city of PCRE transgene expression in ¢ve PCRE founder lines during embryo development
Line Dorsal root ganglia Trigeminal ganglia Olfactory epithelium Sympathetic chain Brainstem nuclei Enteric neurons
11 (E13) +/3 + + 3 + 3
25 (E13) + + + 3 3 3
59 (E13) + + + 3 3 3
35 (E13) + + + 3 3 3
35 (E10) 3 3 3 3 3 3
35 (E11) 3 3 3 3 3 3
35 (E16) + + + + 3 3
PCRE transgene expression was tested by detecting L-galactosidase activity in the tissues of mice embryos carrying ROSA26 lacZ reporter gene
and peripherin-Cre transgene. L-Galactosidase activity was evaluated qualitatively. Its presence and absence are indicated as + and 3, respec-
tively.
Fig. 2. Histochemical analysis of the L-galactosidase activity in an
E14 embryo. A: Sagittal section of a PCRE line 35UR26R cross
embryo. L-Galactosidase expression is detected in trigeminal ganglia
(V) and dorsal root ganglia (DRG) with no ectopic expression in
the central nervous system (F, forebrain: H, hindbrain; M, mid-
brain). B: Sagittal section of a line 35UR52R cross embryo at the
level of the sympathetic chain (SC) showing lacZ expression.
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tage of the ubiquitous expression of the ROSA26 gene. The
fact that R26R is a knock-in adds to the reliability and re-
producibility of the lacZ expression pattern obtained and
avoids the confounding issues of penetrance and site of inser-
tion e¡ects that often add variability to the results when using
a transgenic reporter line [8,18].
The present study con¢rms earlier work that the peripherin
gene 5.8 kb upstream promoter region and 1.1 kb intragenic
sequences can direct transgene expression speci¢cally to pe-
ripheral neurons [7]. Four of ¢ve PCRE transgenic lines have
functional levels of Cre recombinase expression in dorsal root
ganglia, cranial nerve V and trigeminal ganglia, olfactory ep-
ithelium, with only one line (line 35) demonstrating sympa-
thetic chain staining. Dorsal root ganglia staining reveals a
relatively uniform and strong Cre activity initiating at E12^
13. Interestingly, lacZ expression was found only in a subset
of peripherin expressing neurons as compared to transgenic
Per-LacZ expression [7]. One can suppose that this subset
involves structures which have the highest level of peripherin
expression. These data are in good agreement with the tissue
speci¢city described for peripherin expression, but are slightly
imperfect when considering the temporal expression of periph-
erin during development [7,15]. X-gal staining in our tests
appeared between E12 and E13, which is about 2^3 days later
than the results of peripherin immunohistochemistry and
analysis of the peripherin-lacZ transgenic mouse [7,15]. One
possible explanation for this might be that the earliest periph-
erin expressing tissues, such as the cervical ventral roots of the
spinal cord and subcardiac regions, do not express the Cre
recombinase in the PCRE transgenic lines. X-gal staining of
E16 embryos indicates that the transgene is still not expressed
at later stages in these regions. An alternative explanation is
that there may be a delay in Cre activity, due to a putative
need for a certain level of accumulation of the enzyme from a
weakly expressing transgene promoter. However, the most
likely explanation is that the slight di¡erences in expression
patterns between the four transgenic lines and transgene ex-
pression vs. peripherin immunohistochemical data probably
re£ect site of chromosomal insertion or local genomic e¡ects
on transgene expression [18]. Despite these slight variations in
expression, there is no apparent ectopic expression of Cre
recombinase in any of the transgenic lines we examined.
Therefore, the present study shows an expression pattern of
Cre recombinase that is nearly identical to that of the endog-
Fig. 3. Peripherin and L-galactosidase expression in an E14 transgenic embryo. Sagittal sections of a peripherin-Cre line 35UR26R cross em-
bryo were stained for lacZ expression (left pictures). The adjacent sections were immunohistochemically stained for peripherin using a polyclon-
al antibody and fast red substrate system (Dako). L-Galactosidase was detected in DRG, trigeminal ganglia and brainstem (mesencephalic nu-
clei of trigeminal nerve).
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enous murine peripherin gene, with a slightly retarded onset
of expression during embryogenesis.
These mouse lines allow deletions in loxP harboring genes
from speci¢c embryonic tissues and stages where the periph-
erin-Cre construct is expressed. This approach could be
adapted to site- and time-speci¢c gene targeting strategies as
described by Metzger and Chambon [19] and Weber et al.
[20], if one requires a speci¢c deletion at latter stages of devel-
opment (i.e. postnatal). Some cell types which express periph-
erin at low levels (e.g. spinal motoneurons and enteric neu-
rons) were not identi¢ed in R26R embryos suggesting that
this peripherin-Cre construct is only expressed su⁄ciently
for loxP excision, in cells with a high level of endogenous
peripherin gene expression. Gene targeting in these cells may
be obtained using future Cre constructs under the control of a
larger peripherin gene promoter such as has been used for a
brain-speci¢c CAMKII gene BAC [21].
Strong Cre recombinase expression with such high speci¢c-
ity to primary sensory neurons of both the dorsal root gan-
glion and trigeminal ganglia, is potentially of great value for
putative Cre-loxP-mediated gene targeting experiments in pe-
ripheral sensory neurons. Since the primary a¡erent neuron is
the primary site of nociception, which carries the nociceptive
information from skin to the spinal cord [22,23], targeted
Cre expression to these neurons should enable testing of can-
didate genes for their role in pain perception in a much more
speci¢c and accurate way than conventional knock-out mod-
els allow.
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